Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates
Rz. Kuang et al., Utilization of the 1,2,5-thiadiazolidin-3-one 1,1 dioxide scaffold in the design of potent inhibitors of serine proteases: SAR studies using carboxylates, BIO MED CH, 8(5), 2000, pp. 1005-1016
A series of carboxylate derivatives based on the 1,2, 5-thiadiazolidin-3-on
e 1,1 dioxide and isothiazolidin-3-one 1,1 dioxide scaffolds has been synth
esized and the inhibitory profile of these compounds toward human leukocyte
elastase (HLE), cathepsin G (Cat G) and proteinase 3 (PR 3) was then deter
mined. Most of the compounds were found to be potent, time-dependent inhibi
tors of elastase, with some of the compounds exhibiting k(inact)/K-I values
as high as 4,928,300 M-1 s(-1). The inhibitory potency of carboxylate deri
vatives based on the 1,2,5-thiadiazolidin-3-one I,1 dioxide platform was fo
und to be influenced by both the pK(a) and the inherent structure of the le
aving group. Proper selection of the primary specificity group (R-1) was fo
und to lead to selective inhibition of HLE over Cat G, however, those compo
unds that inhibited HLE also inhibited PR 3, albeit less efficiently. The p
redictable mode of binding of these compounds suggests that, among closely-
related serine proteases, highly selective inhibitors of a particular serin
e protease can be fashioned by exploiting subtle differences in their S' su
bsites. This study has also demonstrated that the degradative action of ela
stase on elastin can be abrogated in the presence of inhibitor 17. (C) 2000
Elsevier Science Ltd. All rights reserved.